TriSalus Life Sciences (TLSI) Amortizatization of Intangibles (2024 - 2025)

TriSalus Life Sciences' (TLSI) quarterly Amortizatization of Intangibles came in at $318000.0 in Q2 2025, up 110.6% year-on-year from $151000.0 in Q2 2024, and up 19.55% quarter-over-quarter from $266000.0 in Q1 2025.

TriSalus Life Sciences (TLSI) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends

TriSalus Life Sciences' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $318000.0 for Q2 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 110.6% year-over-year to $318000.0 in Q2 2025; TTM through Jun 2025 was $1.0 million, a 586.75% increase from a year earlier, with the FY2024 full-year figure at $604000.0, changed N/A from the prior year.
  • Amortizatization of Intangibles climbed to $318000.0 in Q2 2025 per TLSI's latest filing, from $266000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $318000.0 in Q2 2025 and bottomed at $151000.0 in Q2 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 TriSalus Life Sciences 222.14 Mn 165.58 Mn 7.67 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 318,000.00
Jun 30, 2025 318,000.00
Mar 31, 2025 266,000.00
Mar 31, 2025 266,000.00
Dec 31, 2024 227,000.00
Dec 31, 2024 227,000.00
Sep 30, 2024 226,000.00
Sep 30, 2024 226,000.00
Jun 30, 2024 151,000.00
Jun 30, 2024 151,000.00